Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.19 +0.00 (+0.00%)
As of: Oct 5, 2026 · 3:45 PM EDT

Drugs Made In America Acquisition (DMII) Receivables - Other (2025)

Updated

Drugs Made In America Acquisition's Receivables - Other was $566,269 in Q3 2025.

Analysis

Drugs Made In America Acquisition (DMII) Receivables - Other (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn -
2 Spdr Gold Trust 133.82 Bn -424.18 Bn -
3 Blackstone 84.08 Bn 79.01 Bn -
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn
5 Kkr 81.05 Bn 47.53 Bn -
6 Brookfield Asset Management 71.64 Bn 67.88 Bn -
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn
10 Drugs Made In America Acquisition 649.10 Mn 649.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 566,269.00
API Access

Drugs Made In America Acquisition Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=DMII&period=max&api_key=YOUR_API_KEY